TI  - Myeloid Toxicity Profile is Related to Treatment Outcome in Trials of Second-Line Hemotherapy of Patients with Metastatic Colorectal Cancer
AU  - Colloca, G.A.
AU  - Venturino, A.
SO  - EJMA 2023;3:177-183.
DO  - 10.14744/ejma.2023.36035